| Application no. and date | 11801741.7 (espacenet) (Federated) (European Patent Register), 20111221 | | Patent/reg. no. and date | DK/EP 2654789, 20180530 | | Publication date | 20131030 | | Priority no. and date | US 201061426041 P, 20101222 | | EP pub. no. and date |
EP 2654789 20131030 | | Effective date | | | Applicant/owner | INSERM - Institut National de la Santé et de la
Recherche Médicale, 101, rue de Tolbiac
75013 Paris, FR,
Orega Biotech, 15 Chemin du Saquin
L'Espace Européen - Bâtiment G
69130 Ecully, FR | | Applicant ref. no. | INN CD39OR2EP | | Inventor | Bensussan, Armand, 16 rue Auguste Lançon
F-75013 Paris, FR,
BASTID, Jérémy, 6 bis Rue des Landes
F-69290 Craponne, FR,
BONNEFOY-BERARD, Nathalie, 8 Rue Marcel Pehu
F-69003 Lyon, FR,
ALBERICI, Gilles, Impasse du Tupinier
les Lauriers
F-69290 Grezieu La Varenne, FR,
ELIAOU, Jean-François, 5 montée de la Lauzière
F-34980 Saint Clément de Rivière, FR | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) , C07K 16/30 (2006.01) | | Title | ANTISTOFFER MOD HUMAN CD39 OG ANVENDELSE DERAF | | Int. application no. | EP2011073659 | | Int. publication no. | WO2012085132 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
